Robinson Thomas Philip, Hubbard Richard B, Ehlers Tedman J, Arbiser Jack L, Goldsmith David J, Bowen J Phillip
Center for Biomolecular Structure and Dynamics, Department of Chemistry, University of Georgia, Athens, GA 30602, USA.
Bioorg Med Chem. 2005 Jun 2;13(12):4007-13. doi: 10.1016/j.bmc.2005.03.054.
Curcumin, a natural product isolated from the spice turmeric, has been shown to exhibit a wide range of pharmacological activities including certain anti-cancer properties. It has been specifically shown to be an effective inhibitor of angiogenesis both in vitro and in vivo. Using curcumin as a lead compound for anti-angiogenic analog design, a series of structurally related compounds utilizing a substituted chalcone backbone have been synthesized and tested via an established SVR cell proliferation assay. The results have yielded a wide range of compounds that equal or exceed curcumin's ability to inhibit endothelial cell growth in vitro. Due to both their commercial availability and their fairly straightforward synthetic preparation, these low molecular weight compounds are attractive leads for developing future angiogenic inhibitors.
姜黄素是从香料姜黄中分离出的一种天然产物,已被证明具有广泛的药理活性,包括某些抗癌特性。具体而言,它在体外和体内均被证明是一种有效的血管生成抑制剂。以姜黄素作为抗血管生成类似物设计的先导化合物,已合成了一系列利用取代查耳酮骨架的结构相关化合物,并通过既定的SVR细胞增殖试验进行了测试。结果得到了多种化合物,它们在体外抑制内皮细胞生长的能力等于或超过姜黄素。由于这些低分子量化合物既具有商业可得性,其合成制备又相当简单,因此是开发未来血管生成抑制剂的有吸引力的先导物。